Next-gen silicon nanotechnology drug delivery company SiSaf raises $3.5 million in Series A Funding
Silicon Valley Investors Lead Funding Round in SiSaf
SiSaf Releases latest Clinical Data Showing a 95% Reduction in Acne
« Previous Page
Find out more.
Okay, thank you